SlideShare a Scribd company logo
1 of 1
Download to read offline
Leading ‘Complete Genomics
& Proteomics’ service
provider in Africa:
MiSeq (1x), IonTorrent PGM
(2x), IonProton (1x), for
high-performance
sequencing projects;
Affymetrix GS 3000 and
Affymetrix GeneTitan for
genoytping and gene-
expression analysis; Tecan LS
and Tecan hyb station for
protein array analysis,
Genetix Qarray 2 for protein
array printing; ABI 4800
MALDI-ToF/ToF and Thermo
Q Exactive for MS-
Proteomics; ABI 7900 and
Roche LC 480 for qRT-PCR
applications; Bioplex system
for multiplex immunoassays;
liquid handling, extraction,
DNA/RNA QC, library
handling and other ancillary
support equipment;
dedicated IT infrastructure
and bioinformatic
applications for data
analysis and interpretation
Value proposition
• To use our expertise in high-quality genomic and proteomic data generation, analysis and
interpretation to deliver outstanding value to customers and partners in Medicine and Health on the
African continent.
• To stimulate, support and drive innovation in Life Science, Translational Medicine, Companion
Diagnostics and Biomarker Development.
• To create and exploit business opportunities in Africa in Precision Medicine and Health.
Background
Situated in Cape Town and built with a vision to contribute towards growing the South African bio-
economy
Track record in working with academia and industry in over 600 projects since 2007
Active across the African continent (e.g., Tunisia, Nigeria, Zimbabwe) and with clients/collaborators
all over the globe
Strongly networked with stakeholders across the life science innovation chain, including academic
researchers, clinical scientists, state funders, technology providers, private investors and life science
industry
Legally se tup as a non-profit organization with strong corporate governance in support of a hybrid
social enterprise model (mixing a strong public benefit mandate and commercial activities)
State of the art quality management (ISO 9001:2008 certification expected July 2014; GLP principles
adhered to in study design)
Strong focus on regional capacity building through training, clustering and networking (e.g. member
of The Biomarker Consortium)
Contact
• www.cpgr.org.za
• www.cpgr.org.za/blogspot/
• reinhard.hiller@cpgr.org.za
• CPGR LinkedIn
• http://za.linkedin.com/in/reinhardhiller

More Related Content

Viewers also liked

Mateo f budinich curriculum-2013
Mateo f budinich curriculum-2013Mateo f budinich curriculum-2013
Mateo f budinich curriculum-2013Mateo Budinich
 
Student'scopymodule8
Student'scopymodule8Student'scopymodule8
Student'scopymodule8Mieyrah Wahab
 
Curriculum Vitae 2011.english
Curriculum Vitae 2011.englishCurriculum Vitae 2011.english
Curriculum Vitae 2011.englishMateo Budinich
 
Tracking your data across the fourth dimension
Tracking your data across the fourth dimensionTracking your data across the fourth dimension
Tracking your data across the fourth dimensionJeremy Cook
 

Viewers also liked (6)

A collection of stories By Ramy George Morcos
A collection of stories By Ramy George MorcosA collection of stories By Ramy George Morcos
A collection of stories By Ramy George Morcos
 
Mateo f budinich curriculum-2013
Mateo f budinich curriculum-2013Mateo f budinich curriculum-2013
Mateo f budinich curriculum-2013
 
Student'scopymodule8
Student'scopymodule8Student'scopymodule8
Student'scopymodule8
 
Curriculum Vitae 2011.english
Curriculum Vitae 2011.englishCurriculum Vitae 2011.english
Curriculum Vitae 2011.english
 
Bab 4
Bab 4 Bab 4
Bab 4
 
Tracking your data across the fourth dimension
Tracking your data across the fourth dimensionTracking your data across the fourth dimension
Tracking your data across the fourth dimension
 

Similar to CPGR snapshot for clients and partners - June 2014

1072729 pp gef_service_core_0512
1072729 pp gef_service_core_05121072729 pp gef_service_core_0512
1072729 pp gef_service_core_0512Elsa von Licy
 
Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...
Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...
Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...ReportsnReports
 
Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...
Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...
Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...Transparency Market Research
 
Bioeast Company Profile.pdf
Bioeast Company Profile.pdfBioeast Company Profile.pdf
Bioeast Company Profile.pdfDanang Setiawan
 
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, MumbaiLab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, MumbaiIndiaMART InterMESH Limited
 
Epi tect methylation qpcr arrays 2013
Epi tect methylation qpcr arrays 2013Epi tect methylation qpcr arrays 2013
Epi tect methylation qpcr arrays 2013Elsa von Licy
 
GeneMind Introduction.pdf
GeneMind Introduction.pdfGeneMind Introduction.pdf
GeneMind Introduction.pdfTylerNguyen40
 
PRAVIN_D_POTDAR.pptx
PRAVIN_D_POTDAR.pptxPRAVIN_D_POTDAR.pptx
PRAVIN_D_POTDAR.pptxOmerBushra4
 
Life_Sciences_Technology__LST__brochure
Life_Sciences_Technology__LST__brochureLife_Sciences_Technology__LST__brochure
Life_Sciences_Technology__LST__brochureRachna Saxena
 
Embrapa Food Technology (Murillo Freire Junior)
Embrapa Food Technology (Murillo Freire Junior)Embrapa Food Technology (Murillo Freire Junior)
Embrapa Food Technology (Murillo Freire Junior)FAO
 
Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Affymetrix
 
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...Yole Developpement
 
Supporting high throughput high-biotechnologies in today’s research environme...
Supporting high throughput high-biotechnologies in today’s research environme...Supporting high throughput high-biotechnologies in today’s research environme...
Supporting high throughput high-biotechnologies in today’s research environme...Ed Dodds
 
Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...
Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...
Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...ReportsnReports
 
LIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry MaxwellLIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry MaxwellCirdan
 

Similar to CPGR snapshot for clients and partners - June 2014 (20)

1072729 pp gef_service_core_0512
1072729 pp gef_service_core_05121072729 pp gef_service_core_0512
1072729 pp gef_service_core_0512
 
Multiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell FunctionMultiplex Assays for Studying Gene Regulation and Cell Function
Multiplex Assays for Studying Gene Regulation and Cell Function
 
Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...
Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...
Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares an...
 
Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...
Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...
Polymerase Chain Reaction (PCR) Market Estimated to Expand at a Robust CAGR b...
 
Bioeast Company Profile.pdf
Bioeast Company Profile.pdfBioeast Company Profile.pdf
Bioeast Company Profile.pdf
 
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, MumbaiLab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
Lab Equipments By Thermo Fisher Scientific India Pvt. Ltd, Mumbai
 
Inqaba biotech presentation
Inqaba biotech presentationInqaba biotech presentation
Inqaba biotech presentation
 
Epi tect methylation qpcr arrays 2013
Epi tect methylation qpcr arrays 2013Epi tect methylation qpcr arrays 2013
Epi tect methylation qpcr arrays 2013
 
GeneMind Introduction.pdf
GeneMind Introduction.pdfGeneMind Introduction.pdf
GeneMind Introduction.pdf
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
Targos_Company_Brochure_lowres
Targos_Company_Brochure_lowresTargos_Company_Brochure_lowres
Targos_Company_Brochure_lowres
 
PRAVIN_D_POTDAR.pptx
PRAVIN_D_POTDAR.pptxPRAVIN_D_POTDAR.pptx
PRAVIN_D_POTDAR.pptx
 
Life_Sciences_Technology__LST__brochure
Life_Sciences_Technology__LST__brochureLife_Sciences_Technology__LST__brochure
Life_Sciences_Technology__LST__brochure
 
Cimna Slide Show October 2009
Cimna Slide Show October 2009Cimna Slide Show October 2009
Cimna Slide Show October 2009
 
Embrapa Food Technology (Murillo Freire Junior)
Embrapa Food Technology (Murillo Freire Junior)Embrapa Food Technology (Murillo Freire Junior)
Embrapa Food Technology (Murillo Freire Junior)
 
Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq Integrating arrays and RNA-Seq
Integrating arrays and RNA-Seq
 
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...
 
Supporting high throughput high-biotechnologies in today’s research environme...
Supporting high throughput high-biotechnologies in today’s research environme...Supporting high throughput high-biotechnologies in today’s research environme...
Supporting high throughput high-biotechnologies in today’s research environme...
 
Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...
Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...
Future Horizons in the UK Cancer Diagnostics Market: Supplier Shares and Sale...
 
LIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry MaxwellLIMS in Modern Molecular Pathology by Dr. Perry Maxwell
LIMS in Modern Molecular Pathology by Dr. Perry Maxwell
 

CPGR snapshot for clients and partners - June 2014

  • 1. Leading ‘Complete Genomics & Proteomics’ service provider in Africa: MiSeq (1x), IonTorrent PGM (2x), IonProton (1x), for high-performance sequencing projects; Affymetrix GS 3000 and Affymetrix GeneTitan for genoytping and gene- expression analysis; Tecan LS and Tecan hyb station for protein array analysis, Genetix Qarray 2 for protein array printing; ABI 4800 MALDI-ToF/ToF and Thermo Q Exactive for MS- Proteomics; ABI 7900 and Roche LC 480 for qRT-PCR applications; Bioplex system for multiplex immunoassays; liquid handling, extraction, DNA/RNA QC, library handling and other ancillary support equipment; dedicated IT infrastructure and bioinformatic applications for data analysis and interpretation Value proposition • To use our expertise in high-quality genomic and proteomic data generation, analysis and interpretation to deliver outstanding value to customers and partners in Medicine and Health on the African continent. • To stimulate, support and drive innovation in Life Science, Translational Medicine, Companion Diagnostics and Biomarker Development. • To create and exploit business opportunities in Africa in Precision Medicine and Health. Background Situated in Cape Town and built with a vision to contribute towards growing the South African bio- economy Track record in working with academia and industry in over 600 projects since 2007 Active across the African continent (e.g., Tunisia, Nigeria, Zimbabwe) and with clients/collaborators all over the globe Strongly networked with stakeholders across the life science innovation chain, including academic researchers, clinical scientists, state funders, technology providers, private investors and life science industry Legally se tup as a non-profit organization with strong corporate governance in support of a hybrid social enterprise model (mixing a strong public benefit mandate and commercial activities) State of the art quality management (ISO 9001:2008 certification expected July 2014; GLP principles adhered to in study design) Strong focus on regional capacity building through training, clustering and networking (e.g. member of The Biomarker Consortium) Contact • www.cpgr.org.za • www.cpgr.org.za/blogspot/ • reinhard.hiller@cpgr.org.za • CPGR LinkedIn • http://za.linkedin.com/in/reinhardhiller